Full Press Release Details
2024 Annual Report and Notice of Annual
Hong Kong, Shanghai, & Florham Park, NJ
- Monday, April 7, 2025: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; HKEX: 13) today announces
that its 2024 Annual Report, together with the Notice of Annual General Meeting and the Form of Proxy ("AGM Materials"),
will be posted on April 8, 2025 to those shareholders who have elected to receive the AGM Materials in printed form. The documents can
also be accessed from the HUTCHMED website (www.hutch-med.com).
The 2025 Annual General Meeting ("AGM")
will be an electronic/hybrid meeting to be held at 1st Floor, Harbour Grand Kowloon, 20 Tak Fung Street, Hung Hom, Kowloon, Hong Kong
on Tuesday, May 13, 2025 at 4:00 pm Hong Kong Time (9:00 am London Time), with online access through an online platform as detailed in
HUTCHMED (Nasdaq/AIM:HCM;
HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the
discovery, global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological
diseases. Since inception, HUTCHMED has focused on bringing drug candidates from in-house discovery to patients around the world, with
its first three medicines marketed in China, the first of which is also approved in the US, Europe and Japan. For more information, please
| Investor Enquiries | +852 2121 8200 / ir@hutch-med.com |
| Media Enquiries | |
| FTI Consulting - | +44 20 3727 1030 / HUTCHMED@fticonsulting.com |
| Ben Atwell / Alex Shaw | +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) |
| Brunswick - Zhou Yi | +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com |
| Panmure Liberum | Nominated Advisor and Joint Broker |
| Atholl Tweedie / Freddy Crossley / Rupert Dearden | +44 20 7886 2500 |
| HSBC | Joint Broker |
| Simon Alexander / Alina Vaskina / Arnav Kapoor | +44 20 7991 8888 |
| Cavendish | Joint Broker |
| Geoff Nash / Nigel Birks | +44 20 7220 0500 |